Cardiometabolic markers Explored in research on lipid profiles, blood pressure, and other metabolic endpoints tied to dual-incretin activity
A separate product, semaglutide subcutaneous injection (Wegovy), is indicated as an adjunct to lifestyle modifications for weight loss and chronic weight management in obese (BMI 30 kg/m2 or greater) or overweight adults (BMI 27 kg/m2 or greater) with at least 1 weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, or dyslipidemia)
Fatigue: Some participants reported fatigue or tiredness during treatment periods
The pituitary gland, dangling from the bottom of our brain, secretes growth hormone in pulses, and this secretion is regulated by two main hormones: somatostatin blocks its release, while growth hormone-releasing hormone (or GHRH), as its name implies, encourages it